G-H-3 International, Inc. Announces Results of Studies Conducted

  
    
  
  
    
      G-H-3 International, Inc. (Pink Sheets: GHTI) announced that Dr. Sidney 
      Cohen and Dr. Keith S. Ditman conducted what might be considered the 
      most extensive and intensive “open studies” 
      research on G-H-3 in this country. Dr. Cohen was one of the most 
      powerful medical figures in Washington, being former director of the 
      Division of Narcotic Addiction and Drug Abuse at the National Institute 
      of Mental Health, and a clinical professor of psychiatry at UCLA.
    
    
      The initial studies indicated that 85% of the patients in the study 
      reported a prompt and dramatic improvement in feelings of depression, 
      relief of insomnia, and general sense of well-being. The most striking 
      result was that cholesterol levels were reduced in 88% of the patients. 
      Additional results related to arthritis showed marked improvement and in 
      some cases complete relief.
    
    
      Dr. Alfred Sapse of UCLA, a renowned ophthalmologist, worked on a grant 
      with the U.S. Institutes of Health and did research on G-H-3 and Dr. 
      Anna Aslan’s work among the elderly. He 
      stated, ”It was so amazing to see these old 
      people given up to die being treated with G-H-3 and then being, well, 
      entirely changed. They were now happy, eager to participate in life 
      around them, able to work and mean something to themselves and others.” 
      Their ailments were either gone or greatly regressed at least to the 
      point where they didn’t bother these old 
      people.
    
    
      These studies are documented in a book authored by Herbert Bailey, WILL 
      IT KEEP YOU YOUNG LONGER? The book was a million-copy best-seller.
    
    
      Flo Ternes, President, CEO of G-H-3, states, “The 
      year 2007 will be an exciting year for the Company as we bring the 
      therapy to our Clinic in Las Vegas.”
    
    
      Safe Harbor Statement
    
    
      Except for historical information contained herein, the matters set 
      forth above may be forward-looking statements that involve certain risks 
      and uncertainties that could cause actual results to differ from those 
      in the forward-looking statements. Words such as "anticipate," 
      "believe," "estimate," "expect," "intend" and similar expressions, as 
      they relate to the Company or its management, identify forward-looking 
      statements. Such forward-looking statements are based on the current 
      beliefs of management, as well as assumptions made by and information 
      currently available to management. Actual results could differ 
      materially from those contemplated by the forward-looking statements as 
      a result of certain factors such as the level of business and consumer 
      spending, the amount of sales of the Company's products, the competitive 
      environment within the industry, the ability of the Company to continue 
      to expand its operations, the level of costs incurred in connection with 
      the Company's expansion efforts, economic conditions in the industry and 
      the financial strength of the Company's customers and suppliers. The 
      Company does not undertake any obligation to update such forward-looking 
      statements. Investors are also directed to consider all other risks and 
      uncertainties.